Overview
Major depressive disorder, often shortened to MDD, is more than ordinary sadness or a passing low mood. It is a clinical condition in which depressed mood or loss of interest and pleasure persists for at least two weeks and is accompanied by shifts in sleep, appetite, energy, thinking, and self-worth that meaningfully affect daily functioning. It is one of the most common conditions worldwide, can begin in adolescence or adulthood, is diagnosed more often in women, and tends to recur across a lifetime. Because mood biology is shaped by far more than any single brain chemical, viewing depression through a full-body optimization lens means also considering inflammation, sleep quality, thyroid and metabolic health, nutrient status, and stress physiology, so the surrounding terrain can be understood alongside a person's own mental health care.
The Underlying Biology
Depression is understood as a complex, multi-system condition rather than a single-molecule deficit. The long-standing monoamine hypothesis focused on serotonin, norepinephrine, and dopamine signaling, but current research emphasizes broader mechanisms. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, with altered cortisol rhythms and impaired feedback, is frequently described. A growing body of work links low-grade neuroinflammation and elevated inflammatory cytokines, such as IL-6, TNF-alpha, and CRP, to depressive symptoms, and explores how immune activation shifts tryptophan down the kynurenine pathway rather than toward serotonin. Reduced neuroplasticity, including lower brain-derived neurotrophic factor (BDNF) and changes in hippocampal and prefrontal circuits, is another active area. Glutamatergic and GABAergic signaling, mitochondrial and oxidative stress, gut-brain and microbiome interactions, and circadian and sleep disruption are all studied as contributors. Overlapping factors including thyroid dysfunction, low vitamin D, B-vitamin and omega-3 status, insulin resistance, and chronic stress are examined for their associations with mood. Commonly discussed markers in research settings include CRP, cortisol patterns, thyroid panels, vitamin D, and metabolic and inflammatory measures.
What the Research Explores
- Explores the role of HPA-axis balance and cortisol rhythms in mood regulation and stress resilience
- Investigates whether inflammatory markers such as CRP and cytokines are associated with depressive symptoms
- Examines how sleep quality, circadian rhythm, and light exposure relate to mood and energy in research
- Studies the connection between thyroid function, metabolic health, and insulin sensitivity and how they intersect with mood
- Considers how nutrient status, including vitamin D, B vitamins, and omega-3s, is studied in relation to brain health
- Investigates how the gut microbiome, exercise, and body composition may relate to neuroplasticity and whole-person wellness
Who May Find This Relevant
- People with a depression diagnosis exploring supportive, whole-person optimization alongside their mental health care
- Those investigating how inflammation, sleep, thyroid, and metabolic health may relate to mood and energy
- Individuals with related labs such as elevated CRP, low vitamin D, or thyroid changes seeking broader context
- Caregivers and partners seeking a clear, science-forward understanding of the condition
Important Considerations
This page is educational only and is not intended to diagnose, treat, cure, or prevent depression or any disease. Major depressive disorder is a medical condition that must be evaluated and managed with your own physician or mental health professional, and whether and how any optimization support fits alongside that care is decided one-on-one with Dr. Rob, based on your labs, history, and goals. If you are in crisis or having thoughts of self-harm, seek immediate help; individual situations vary, and these statements have not been evaluated by the FDA.
